Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Sep 8, 2026– Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical nee…